HOME Top Market Reports Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017

Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017

By: marketsandmarkets.com
Publishing Date: January 2013
Report Code: MD 1407

Discount on Reports  

  Speak to Analyst Enquiry Before Buying
Analyst Briefing  
purchase report
download pdf  request for customisation


Apheresis is a process in which blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of separated component. This process involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. The global market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017 growing at a CAGR of 11.0% from 2012 to 2017. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.

This market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market.

North America holds the largest market share of close to 50%, followed by Europe in 2012. In the next five years, emerging countries are estimated to register the highest growth rate, primarily due to increasing investments and huge demand for blood components from countries like China and India with large population.

The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack.

Scope of the Report

The research report categorizes this market into procedure, application, technology, product type and end-user. All these markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the apheresis market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.
Global Market segmentation:

  • By Procedure:
    • Donor Apheresis
    • Therapeutic Apheresis
      • Neurologic Disorders
      • Blood Disorders (TTP, Leukemia, & Others)
      • Renal Disease
      • Metabolic Disorders
      • Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others)
  • By Application:
    • Plasmapheresis
    • Plateletpheresis
    • Erythrocytapheresis
    • Leukoreduction/leukapheresis
    • Others (photopheresis, lipidpheresis, and Immunoadsoption)
  • By Technology:
    • Centrifugation
    • Membrane Separation/Filtration
  • By Product type:
    • Devices
    • Disposables
  • By End-user:
    • Blood banks/Blood collection centers
    • Hospitals & Hospital attached blood banks
    • Others
  • By Geography:
    • North America
    • Europe
    • Asia
    • RoW (Rest of the World)

Each section of the report also provides market trends with respect to drivers, restraints, and opportunities. The report includes 13 company profiles and its competitive landscape section sketches the strategic developments in the market.

TABLE OF CONTENTS
 
1 INTRODUCTION
  1.1 KEY TAKE AWAYS
  1.2 REPORT DESCRIPTION
  1.3 MARKETS COVERED
  1.4 STAKEHOLDERS
  1.5 RESEARCH METHODOLOGY
      1.5.1 MARKET SIZE
      1.5.2 MARKET SHARE
      1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
      1.5.4 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
  3.1 INTRODUCTION
  3.2 MARKET SEGMENTATION
  3.3 MARKET DYNAMICS
      3.3.1 DRIVERS
            3.3.1.1 BLOOD SHORTAGE & BLOOD SAFETY TO INCREASE THE DEMAND FOR APHERESIS BLOOD
            3.3.1.2 ADVANTAGE OF APHERESIS COLLECTION OVER WHOLE BLOOD COLLECTION TO BOOST THE GROWTH
            3.3.1.3 INCREASING DEMAND FOR PLASMA DERIVED PRODUCTS TO SPUR THE APHERESIS MARKET
            3.3.1.4 INCREASE IN AGING POPULATION DEMANDS GROWTH OF APHERESIS
      3.3.2 RESTRAINTS
            3.3.2.1 LACK OF AWARENESS & CHALLENGES IN DONOR RECRUITMENT TO RESTRICT THE GROWTH OF APHERESIS
            3.3.2.2 HIGH COST OF APHERESIS PROCEDURES TO HINDER THE ACCEPTABILITY
      3.3.3 OPPORTUNITIES
            3.3.3.1 EXTENDING REACH OF APHERESIS
            3.3.3.2 UNTAPPED PEDIATRIC SEGMENT CAN SOON GAIN IMPORTANCE IN APHERESIS
  3.4 MARKET SHARE ANALYSIS
  3.5 END-USER ANALYSIS

4 GLOBAL MARKET, BY PROCEDURE
  4.1 INTRODUCTION
  4.2 AUTOMATED/APHERESIS BLOOD COLLECTION (DONOR APHERESIS)
  4.3 THERAPEUTIC APHERESIS
      4.3.1 NEUROLOGIC DISORDERS
      4.3.2 BLOOD DISORDERS
      4.3.3 RENAL DISORDERS
      4.3.4 METABOLIC DISORDERS
      4.3.5 OTHER DISORDERS

5 GLOBAL MARKET, BY PRODUCT TYPE
  5.1 INTRODUCTION
  5.2 DEVICES
  5.3 DISPOSABLES

6 GLOBAL MARKET, BY TECHNOLOGY
  6.1 INTRODUCTION
  6.2 CENTRIFUGATION
      6.2.1 DRIVER & RESTRAINT
            6.2.1.1 ADVANTAGES OFFERED BY CENTRIFUGATION TECHNOLOGY OVER MEMBRANE SEPARATION
            6.2.1.2 CENTRIFUGATION APHERESIS PROCESS IS TIME-CONSUMING
  6.3 MEMBRANE SEPARATION

7 GLOBAL MARKET, BY APPLICATION
  7.1 INTRODUCTION
  7.2 PLASMAPHERESIS
      7.2.1 DRIVERS
            7.2.1.1 HUGE DEMAND FOR PLASMA FROM BIOPHARMACEUTICAL COMPANIES
            7.2.1.2 NEW APPLICATIONS AND OPPORTUNITIES IN DEVELOPING COUNTRIES
  7.3 PLATELETPHERESIS
  7.4 ERYTHROCYTAPHERESIS
  7.5 LEUKAPHERESIS
  7.6 OTHERS

8 GEOGRAPHIC ANALYSIS
  8.1 INTRODUCTION
  8.2 NORTH AMERICA
  8.3 EUROPE
  8.4 ASIA
  8.5 ROW (REST OF THE WORLD)

9 COMPETITIVE LANDSCAPE
  9.1 INTRODUCTION
  9.2 MERGERS & ACQUISITIONS
  9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 127
  9.4 PRODUCTS LAUNCH
  9.5 EXPANSIONS
  9.6 OTHER DEVELOPMENTS
  9.7 APPROVALS

10 COMPANY PROFILES(OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)*
  10.1 ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF
  10.2 B. BRAUN MELSUNGEN AG
  10.3 CERUS CORPORATION
  10.4 FENWAL, INC.
  10.5 FRESENIUS MEDICAL CARE AG & CO. KGAA
  10.6 HAEMONETICS CORPORATION
  10.7 HEMACARE CORPORATION
  10.8 KANEKA CORPORATION
  10.9 KAWASUMI LABORATORIES, INC.
  10.1 MEDICA S.P.A
  10.11 NIKKISO CO., LTD.
  10.12 TERUMO BCT, INC.
  10.13 THERAKOS, INC.
*DETAILS ON FINANCIALS, PRODUCT & SERVICES, STRATEGY, & DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
 
 
LIST OF TABLES 
 
TABLE 1 GLOBAL MARKET, BY PROCEDURE, 2010 2017 ($MILLION)
TABLE 2 PEDIATRIC TRANSFUSIONS IN U.S. BY BLOOD CENTERS AND HOSPITALS IN 2008 (THOUSANDS OF UNITS)
TABLE 3 GLOBAL MARKET, BY END-USER, 2010 2017 ($MILLION)
TABLE 4 BLOOD BANKS & BLOOD COLLECTION CENTERS APHERESIS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 5 HOSPITALS & HOSPITAL ATTACHED BLOOD BANKS APHERESIS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 6 OTHERS APHERESIS END-USER MARKET, BY GEOGRAPHY,2010 2017 ($MILLION)
TABLE 7 GLOBAL APHERESIS (DONOR & THERAPEUTIC APHERESIS) MARKET,BY PROCEDURE, 2010 2017 ($MILLION)
TABLE 8 AUTOMATED BLOOD COLLECTION MARKET, BY GEOGRAPHY,2010 2017 ($MILLION)
TABLE 9 TYPES OF THERAPEUTIC APHERESIS PROCEDURES
TABLE 10 THERAPEUTIC APHERESIS MARKET, BY GEOGRAPHY,2010 2017 ($MILLION)
TABLE 11 DISEASE/DISORDER TREATED BY THERAPEUTIC APHERESIS
TABLE 12 GLOBAL THERAPEUTIC APHERESIS MARKET, BY DISEASE,2010 - 2017 ($MILLION)
TABLE 13 NEUROLOGIC DISORDERS - THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 14 BLOOD DISORDERS - THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 15 BLOOD DISORDERS THERAPEUTIC APHERESIS MARKET,BY DISEASES, 2010 2017 ($MILLION)
TABLE 16 TTP THERAPEUTIC APHERESIS MARKET, BY GEOGRAPHY,2010 2017 ($MILLION)
TABLE 17 LEUKEMIA THERAPEUTIC APHERESIS MARKET, BY GEOGRAPHY,2010 2017 ($MILLION)
TABLE 18 OTHER BLOOD DISORDER THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 19 RENAL DISORDERS - THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 20 METABOLIC DISORDERS - THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 21 OTHER DISORDERS - THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 22 GLOBAL MARKET, BY PRODUCT TYPE,2010 2017 ($MILLION)
TABLE 23 APHERESIS DEVICES MARKET, BY GEOGRAPHY,2010 2017 ($MILLION)
TABLE 24 APHERESIS DEVICES MARKET, BY APPLICATIONS,2010 - 2017 ($MILLION)
TABLE 25 APHERESIS DEVICES/SYSTEMS IN THE MARKET
TABLE 26 APHERESIS DISPOSABLES MARKET, BY GEOGRAPHY,2010 2017 ($MILLION)
TABLE 27 GLOBAL APHERESIS DISPOSABLES MARKET, BY APPLICATION,2010 2017 ($MILLION)
TABLE 28 GLOBAL MARKET, BY TECHNOLOGY,2010 2017 ($MILLION)
TABLE 29 DENSITY OF BLOOD COMPONENTS (KG/L)
TABLE 30 CENTRIFUGATION TECHNOLOGY BASED APHERESIS DEVICES
TABLE 31 CENTRIFUGATION-BASED APHERESIS MARKET, BY GEOGRAPHY,2010 2017 ($MILLION)
TABLE 32 NORTH AMERICA: CENTRIFUGATION APHERESIS MARKET,BY COUNTRY, 2010 2017 ($MILLION)
TABLE 33 EUROPE: CENTRIFUGATION APHERESIS MARKET, BY COUNTRY,2010 2017 ($MILLION)
TABLE 34 ASIA: CENTRIFUGATION APHERESIS MARKET, BY COUNTRY,2010 2017 ($MILLION)
TABLE 35 ROW: CENTRIFUGATION APHERESIS MARKET, BY COUNTRY,2010 2017 ($MILLION)
TABLE 36 SIZE OF BLOOD COMPONENTS
TABLE 37 MEMBRANE SEPARATION APHERESIS DEVICES
TABLE 38 MEMBRANE SEPARATION-BASED APHERESIS MARKET, BY GEOGRAPHY, 2010 2017 ($MILLION)
TABLE 39 NORTH AMERICA: MEMBRANE SEPARATION APHERESIS MARKET,BY COUNTRY, 2010 2017 ($MILLION)
TABLE 40 EUROPE: MEMBRANE SEPARATION APHERESIS MARKET,BY COUNTRY, 2010 2017 ($MILLION)
TABLE 41 ASIA: MEMBRANE SEPARATION APHERESIS MARKET, BY COUNTRY, 2010 2017 ($MILLION)
TABLE 42 ROW: MEMBRANE SEPARATION APHERESIS MARKET, BY COUNTRY, 2010 2017 ($MILLION)
TABLE 43 GLOBAL MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 44 PLASMA COLLECTION IN UNITED STATES FROM 2005 TO 2010 (THOUSAND LITERS)
TABLE 45 PLASMAPHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 46 GLOBAL PLASMAPHERESIS MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 47 PLATELETPHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 48 GLOBAL PLATELETPHERESIS MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 49 ERYTHROCYTAPHERESIS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 50 GLOBAL ERYTHROCYTAPHERESIS MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 51 LEUKAPHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 52 GLOBAL LEUKAPHERESIS MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 53 OTHER APHERESIS APPLICATION MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 54 APHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 55 NORTH AMERICA: APHERESIS MARKET, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 56 NORTH AMERICA: MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 57 NORTH AMERICA: MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 58 NORTH AMERICA: MARKET, BY TECHNOLOGY,2010 - 2017 ($MILLION)
TABLE 59 NORTH AMERICA: MARKET, BY PRODUCT TYPE,2010 - 2017 ($MILLION)
TABLE 60 NORTH AMERICA: MARKET, BY END-USER,2010 - 2017 ($MILLION)
TABLE 61 EUROPE: APHERESIS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 62 EUROPE: MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 63 EUROPE: MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 64 EUROPE: MARKET, BY TECHNOLOGY,2010 - 2017 ($MILLION)
TABLE 65 EUROPE: MARKET, BY PRODUCT TYPE,2010 2017 ($MILLION)
TABLE 66 EUROPE: MARKET, BY END-USER, 2010 - 2017 ($MILLION)
TABLE 67 ASIA: APHERESIS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 68 ASIA: MARKET, BY PROCEDURE, 2010 - 2017 ($MILLION)
TABLE 69 ASIA: MARKET, BY APPLICATION, 2010 - 2017 ($MILLION)
TABLE 70 ASIA: MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
TABLE 71 ASIA: MARKET, BY PRODUCT TYPE,2010 - 2017 ($MILLION)
TABLE 72 ASIA: MARKET, BY END-USER, 2010 - 2017 ($MILLION)
TABLE 73 ROW: APHERESIS MARKET, BY REGION, 2010 - 2017 ($MILLION)
TABLE 74 ROW: MARKET, BY PROCEDURE, 2010 - 2017 ($MILLION)
TABLE 75 ROW: MARKET, BY APPLICATION, 2010 - 2017 ($MILLION)
TABLE 76 ROW: MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
TABLE 77 ROW: MARKET, BY PRODUCT TYPE,2010 - 2017 ($MILLION)
TABLE 78 ROW: MARKET, BY END-USER, 2010 - 2017 ($MILLION)
TABLE 79 MERGERS & ACQUISITIONS, 2010 2012
TABLE 80 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, 2010 2012
TABLE 81 PRODUCTS LAUNCH, 2010 2012
TABLE 82 EXPANSIONS, 2010 2012
TABLE 83 OTHER DEVELOPMENTS, 2010 2012
TABLE 84 APPROVALS, 2010 2012
TABLE 85 ASAHI KASEI MEDICAL CO., LTD: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 86 B. BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 87 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENT,2009 2011 ($MILLION)
TABLE 88 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY,2009 2011 ($MILLION)
TABLE 89 CERUS CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE,2009 2011 ($MILLION)
TABLE 90 FRESENIUS MEDICAL CARE AG: TOTAL REVENUE AND R&D EXPENDITURE, 2009 2011 ($MILLION)
TABLE 91 FRESENIUS MEDICAL CARE AG: TOTAL REVENUE, BY SEGMENT,2009 2011 ($MILLION)
TABLE 92 FRESENIUS MEDICAL CARE AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 2011 ($MILLION)
TABLE 93 HAEMONETICS: TOTAL REVENUE AND R&D EXPENDITURE,2009 2011 ($MILLION)
TABLE 94 HAEMONETICS: TOTAL REVENUE, BY SEGMENT,2009 2011 ($MILLION)
TABLE 95 HAEMONETICS: DISPOSABLES REVENUE, BY PRODUCT TYPE,2009 2011 ($MILLION)
TABLE 96 HAEMONETICS: TOTAL REVENUE, BY GEOGRAPHY,2009 2011 ($MILLION)
TABLE 97 KANEKA CORPORATION: TOTAL REVENUE, BY SEGMENT,2010 2012 ($MILLION)
TABLE 98 KAWASUMI LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2008 2010 ($MILLION)
TABLE 99 KAWASUMI LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENT,2008 2010 ($MILLION)
TABLE 100 NIKKISO CO., LTD: TOTAL REVENUE AND R&D EXPENDITURE,2010 2012 ($MILLION)
TABLE 101 NIKKISO CO., LTD: TOTAL REVENUE, BY GEOGRAPHY,2010 2012 ($MILLION)
 
 
LIST OF FIGURES
 
FIGURE 1 GLOBAL MARKET, BY APPLICATION, 2012
FIGURE 2 BLOOD INDUSTRY VALUE CHAIN
FIGURE 3 APHERESIS MARKET SEGMENTATION
FIGURE 4 APHERESIS MARKET - DRIVERS & RESTRAINTS
FIGURE 5 GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2011
FIGURE 6 KEY GROWTH STRATEGIES, 2010 2012

 

Apheresis is a process wherein blood is collected and separated into different components, leveraging on centrifugation and membrane separation technology. The global market is valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017, growing at a CAGR of 11% from 2012 to 2017.

The market studied in this report is segmented by procedure, application, technology, product type, and end-user. Based on the rationale of the apheresis procedure, the market is segmented as automated blood collection (donor) and therapeutic apheresis. Automated blood collection accounts for the largest share of the global market, by procedure, in 2012. The application market is divided into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis and others, while technology market is classified as centrifugation & membrane separation/filtration in which the former leads the market in 2012. This share can be attributed to the use of centrifugation apheresis devices, mostly by blood banks for collection, and for therapeutics as well due to the advantages offered by centrifugation technology over membrane separation. Centrifugation is used for the apheresis of any blood component whereas the use of membrane separation is limited to plasma exchange. The product types used in this market are majorly classified as devices and disposables.

Increasing blood shortage, advantages of apheresis collection over whole blood and increasing demand for plasma from biopharmaceutical companies are the major drivers that are slated to propel this market. However, donor recruitment and high cost of the apheresis are the major challenges for the growth. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.

North America holds the largest market share of close to 50%, followed by Europe in 2012. In the next five years, emerging countries are estimated to register the highest growth rate, primarily due to increasing investments and huge demand for blood components from countries like China and India with large population.

The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),  Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack.

APHERESIS MARKET REVENUE, BY APPLICATION, 2012

Apheresis Market

Plasmapheresis segment leads the apheresis application market in 2012, due to the huge demand for human plasma from biopharmaceutical companies for the production of plasma-derived proteins.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports